One of the mechanisms for tumor cell-stimulated expression of PD-L1 is the activation of the EGFR, ERK1/2, PI3K-Akt, or Janus kinase 2/STAT1 signaling pathways [46]. This evidence concerns the gene AKT1 and neoplasm.